Type 2 Balanced Thc Cbd

Type 2 cannabis genetics are defined by relatively balanced ratios of THC to CBD, typically ranging from 1:1 to 3:1 THC-to-CBD. These plants produce significant quantities of both major cannabinoids, a trait that emerged prominently through selective breeding in the 1990s and 2000s, particularly in European and North American breeding programs. Type 2 chemistry differs from Type 1 (THC-dominant) and Type 3 (CBD-dominant) classifications established by cannabis researcher Dr. Ethan Russo. Lineage records frequently report Type 2 expression in crosses between high-THC cultivars and CBD-rich genetics, requiring breeders to stabilize ratios across generations. The biochemical pathway producing both cannabinoids in measurable quantities remains an area of ongoing cultivation study.

Breeders working in the Type 2 category employ marker-assisted selection and progeny testing to achieve consistent balanced ratios, as this phenotype can be unstable across generations. Stabilizing Type 2 expression is valuable for breeding programs seeking versatile parental lines for creating diverse cannabinoid profiles in descendant cultivars.